Vest Financial’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.1M Buy
36,383
+588
+2% +$33.8K 0.02% 326
2026
Q1
$2.17M Sell
35,795
-1,699
-5% -$99K 0.03% 313
2025
Q4
$2.02M Buy
37,494
+8,335
+29% +$401K 0.03% 314
2025
Q3
$1.32M Buy
29,159
+5,610
+24% +$262K 0.02% 333
2025
Q2
$1.09M Buy
23,549
+6,637
+39% +$326K 0.02% 334
2025
Q1
$1.03M Buy
16,912
+7,166
+74% +$418K 0.02% 315
2024
Q4
$551K Buy
9,746
+1,271
+15% +$71K 0.01% 258
2024
Q3
$438K Buy
+8,475
New +$398K 0.01% 260

Other funds holding BMY

Vest Financial's BMY Position: Q2 2026 in Review

Vest Financial increased its Bristol-Myers Squibb (BMY) stake by 1.6% in Q2 2026, buying an estimated $33.8K and bringing the position to 36,383 shares worth $2.1M. The position accounts for 0.02% of the portfolio, ranked #326.

Vest Financial first reported a position in BMY in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.17M in Q1 2026. 878 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Vest Financial held 36,383 shares of Bristol-Myers Squibb worth $2.1M as of Q2 2026.
  • Vest Financial bought 588 Bristol-Myers Squibb shares in Q2 2026, an estimated $33.8K.
  • Bristol-Myers Squibb made up 0.02% of Vest Financial's portfolio in Q2 2026, its #326 holding.
  • Vest Financial first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 8 quarters since.
  • Vest Financial's Bristol-Myers Squibb position peaked at $2.17M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Vest Financial's 13F filing for Q2 2026, filed 24 Jul 2026.